4//SEC Filing
SCHIERMEIER ANDREW 4
Accession 0001209191-21-018326
CIK 0001652130other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:53 PM ET
Size
8.2 KB
Accession
0001209191-21-018326
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Award
Stock Option (right to buy)
2021-03-03+78,750→ 78,750 totalExercise: $57.71Exp: 2031-03-02→ Common Stock (78,750 underlying) - Award
Restricted Stock Unit
2021-03-03+13,125→ 13,125 total→ Common Stock (13,125 underlying)
Footnotes (2)
- [F1]This option was granted on March 3, 2021 with respect to 78,750 shares of Common Stock, with 25% vesting on January 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
- [F2]On March 3, 2021, the reporting person was granted 13,125 Restricted Stock Units ("RSUs") pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001738456
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:53 PM ET
- Size
- 8.2 KB